Skip to search formSkip to main contentSkip to account menu

nipradilol

Known as: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The present study was performed to evaluate the intraocular pressure (IOP)-lowering effect of nipradilol in combination with… 
Highly Cited
2002
Highly Cited
2002
Purpose. To determine whether nipradilol, a new antiglaucoma drug, can protect retinal ganglion cells (RGCs) from secondary cell… 
2000
2000
AIMS To study the effects of topical nipradilol, a non-selective beta blocker with alpha blocking and nitroglycerin-like… 
1998
1998
PURPOSE To study the effects of nipradilol, a nonselective beta-blocker with alpha 1-blocking activity and nitroglycerin-like… 
1998
1998
Objectives To assess the effects of a vasodilatory β -adrenoceptor blocker, nipradilol, and a long-acting Ca channel blocker… 
1996
1996
The effects of nipradilol, an ocular hypotensive drug, on isolated canine retinal central arteries and on retinal arterioles in… 
1985
1985
Nipradilol competitively antagonized norepinephrine- or phenylephrine-induced contractile responses of guinea-pig thoracic aorta…